Arrowstreet Capital
XERS icon

Arrowstreet Capital’s Xeris Biopharma Holdings XERS Stock Holding History

Arrowstreet Capital’s Portfolio XERS Stock Details XERS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$7.71M Buy
972,880
+839,120
+627% +$5.36M ﹤0.01% 1169
2026
Q1 		$776K Sell
133,760
-81,026
-38% -$537K ﹤0.01% 1605
2025
Q4 		$1.69M Buy
+214,786
New +$1.69M ﹤0.01% 1448
2020
Q3 		– Sell
-42,000
Closed -$112K – 2547
2020
Q2 		$112K Buy
+42,000
New +$146K ﹤0.01% 2217

Other funds holding XERS

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Nuveen
Nuveen Charlotte, North Carolina $419B AUM 43.02% 1-Year Est. Return
RA
Rosalind Advisors Toronto, Ontario, Canada $269M AUM 103.38% 1-Year Est. Return
Qube Research & Technologies (QRT)
Qube Research & Technologies (QRT) London, United Kingdom $108B AUM 37.29% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Arrowstreet Capital's XERS Position: Q2 2026 in Review

Arrowstreet Capital increased its Xeris Biopharma Holdings (XERS) stake by 627% in Q2 2026, buying an estimated $5.36M and bringing the position to 972,880 shares worth $7.71M. The position accounts for ﹤0.01% of the portfolio, ranked #1169.

Arrowstreet Capital first reported a position in XERS in Q2 2020 and has held it in 4 quarters since. 239 funds tracked by Wall St. Rank hold XERS as of Q2 2026.

  • Arrowstreet Capital held 972,880 shares of Xeris Biopharma Holdings worth $7.71M as of Q2 2026.
  • Arrowstreet Capital bought 839,120 Xeris Biopharma Holdings shares in Q2 2026, an estimated $5.36M.
  • Xeris Biopharma Holdings made up ﹤0.01% of Arrowstreet Capital's portfolio in Q2 2026, its #1169 holding.
  • Arrowstreet Capital first reported a position in Xeris Biopharma Holdings in Q2 2020 and has held it in 4 quarters since.
  • 239 funds tracked by Wall St. Rank held Xeris Biopharma Holdings as of Q2 2026.

Based on Arrowstreet Capital's 13F filing for Q2 2026, filed 13 Aug 2026.